Neurogene Stock

neurogene.comBioTechFounded: 2018Funding to Date: $183.58MM

Neurogene develops life-changing genetic medicines for patients and their families affected by rare, devastating neurological diseases.

Enterprise Value (based on primary financings)

Register for Details

For more details on financing and valuation for Neurogene, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

Already registered? Click here to log in

Enterprise Value (based on primary financings)

Enterprise Value

View Enterprise Value for Neurogene.

Register Today
Register for Details

For more details on financing and valuation for Neurogene, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

Already registered? Click here to log in

Other companies like Neurogene in the BioTech sector

Sector
 
 
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$500MM
Sector
Last Round Est. Valuation
$185MM
Sector
Last Round Est. Valuation
$1.3B
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$50.4MM
Sector
Last Round Est. Valuation
$4.89B